{"id":1737795,"date":"2025-05-01T22:32:17","date_gmt":"2025-05-01T17:02:17","guid":{"rendered":"https:\/\/pharmint.net\/?p=1737795"},"modified":"2025-05-14T17:22:33","modified_gmt":"2025-05-14T11:52:33","slug":"qdenga-dengue-vaccine-global-trade","status":"publish","type":"post","link":"https:\/\/pharmint.net\/fr\/qdenga-dengue-vaccine-global-trade\/","title":{"rendered":"Rising Demand for Dengue Vaccines: How Qdenga and Global Pharma Trade Are Stepping Up"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_74 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/pharmint.net\/fr\/qdenga-dengue-vaccine-global-trade\/#Conclusion\" >Conclusion<\/a><\/li><\/ul><\/nav><\/div>\n\n<figure class=\"wp-block-image size-large\"><img data-dominant-color=\"d29f79\" data-has-transparency=\"false\" style=\"--dominant-color: #d29f79;\" fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"574\" src=\"https:\/\/pharmint.net\/wp-content\/uploads\/2025\/05\/Dengue_Content-width-banner-1024x574.webp\" alt=\"Bulk Wholesale Supplies\" class=\"not-transparent wp-image-1737796\" title=\"Wholesale\" srcset=\"https:\/\/pharmint.net\/wp-content\/uploads\/2025\/05\/Dengue_Content-width-banner-1024x574.webp 1024w, https:\/\/pharmint.net\/wp-content\/uploads\/2025\/05\/Dengue_Content-width-banner-300x168.webp 300w, https:\/\/pharmint.net\/wp-content\/uploads\/2025\/05\/Dengue_Content-width-banner-150x84.webp 150w, https:\/\/pharmint.net\/wp-content\/uploads\/2025\/05\/Dengue_Content-width-banner-768x431.webp 768w, https:\/\/pharmint.net\/wp-content\/uploads\/2025\/05\/Dengue_Content-width-banner-1536x862.webp 1536w, https:\/\/pharmint.net\/wp-content\/uploads\/2025\/05\/Dengue_Content-width-banner-jpg.webp 2000w\" sizes=\"(max-width: 1024px) 100vw, 1024px\"><\/figure>\n\n\n\n<p>As dengue cases surge worldwide, demand for effective vaccines is rising fast. Qdenga, a dengue vaccine developed by Takeda, is gaining traction in key markets across Asia and Latin America. Its broad approval and strong efficacy make it a critical tool in public health campaigns.<\/p>\n\n\n\n<p>Governments and global health organizations are accelerating vaccine procurement. Qdenga&rsquo;s approval in the EU and endorsements by the WHO are opening doors for global distribution.<\/p>\n\n\n\n<p>Pharma companies are scaling production and expanding supply chains to meet demand. Strategic partnerships and fast-track approvals are helping vaccines reach high-risk regions faster.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Key Points:<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Dengue infections are climbing globally, especially in tropical regions.<\/li>\n\n\n\n<li>Qdenga is leading vaccine rollout with wide regulatory support.<\/li>\n\n\n\n<li>Global pharma trade is focusing on speed, accessibility, and scale.<\/li>\n<\/ul>\n\n\n\n<p>As climate change, urbanization, and global travel fuel the spread of vector-borne diseases, <strong>dengue fever<\/strong> is emerging as a growing global health crisis. The <strong>World Health Organization (WHO)<\/strong> estimates that nearly <strong>half of the world&rsquo;s population is now at risk of dengue<\/strong>, particularly in <strong>Asia, Latin America, and Africa<\/strong>.<\/p>\n\n\n\n<p>In response to this rising threat, <strong>Japanese pharmaceutical giant Takeda<\/strong> has developed <strong>Qdenga (TAK-003)<\/strong> &mdash; a <strong>tetravalent dengue vaccine<\/strong> that is already making headlines for its <strong>broad efficacy<\/strong> and <strong>global regulatory approvals<\/strong>. This game-changing innovation underscores the vital role of <strong>international pharmaceutical companies<\/strong> and <strong>cross-border pharma trade<\/strong> in combating public health threats.<\/p>\n\n\n\n<h3 class=\"wp-block-heading alignwide\">Qdenga and the Global Push Against Dengue: A New Chapter in Preventive Healthcare<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Over <strong>390 million dengue infections<\/strong> occur annually.<\/li>\n\n\n\n<li>Endemic in <strong>over 100 countries<\/strong>, particularly in tropical and subtropical regions.<\/li>\n\n\n\n<li>High burden in <strong>developing countries<\/strong>, where access to preventive vaccines has been limited.<\/li>\n<\/ul>\n\n\n\n<p>Dengue fever is becoming a major global health threat, driven by climate change, urbanization, and increased travel. According to the World Health Organization (WHO), nearly <strong>50% of the world&rsquo;s population<\/strong> is at risk, especially in <strong>Asia, Latin America, and Africa<\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading alignwide\"><a href=\"Qdenga:%20Takeda%E2%80%99s%20Global-Ready%20Dengue%20Vaccine\">Qdenga: A Global Solution by a Global Player<\/a><\/h3>\n\n\n\n<p>In response, <strong>Takeda Pharmaceuticals<\/strong> has introduced <strong>Qdenga (TAK-003)<\/strong> &mdash; a <strong>tetravalent dengue vaccine<\/strong> designed for broad protection. Already approved in the <strong>EU, Brazil, Indonesia, Thailand, and Argentina<\/strong>, Qdenga is positioned to become a <strong>key export in global pharma trade<\/strong>.<\/p>\n\n\n\n<p><strong>Target recipients include:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>People living in dengue-endemic regions<\/li>\n\n\n\n<li>Travelers to tropical areas<\/li>\n\n\n\n<li>Public health initiatives combating outbreaks<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Demand for Dengue Vaccines Is Surging<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Over <strong>390 million<\/strong> dengue infections occur yearly<\/li>\n\n\n\n<li>Dengue is endemic in <strong>100+ countries<\/strong><\/li>\n\n\n\n<li>Access to preventive vaccines has been limited in many regions<\/li>\n<\/ul>\n\n\n\n<p>This makes vaccines like Qdenga essential &mdash; not just for healthcare, but for <strong>international pharmaceutical trade<\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Cross-Border Trade and Digital Pharma Platforms<\/strong><\/h3>\n\n\n\n<p>To reach global markets, vaccines need:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Cold chain logistics<\/li>\n\n\n\n<li>Regulatory documentation (e.g., COA, MSDS)<\/li>\n\n\n\n<li>WHO-GMP-compliant suppliers<\/li>\n<\/ul>\n\n\n\n<p>Platforms like <strong>Pharmint<\/strong> streamline this process by connecting verified pharma suppliers with global buyers. They offer:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Real-time pricing and supply visibility<\/li>\n\n\n\n<li>Simplified compliance and import\/export support<\/li>\n\n\n\n<li>Secure payments and logistics integration<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>The Future of Global Vaccine Sourcing<\/strong><\/h3>\n\n\n\n<p>Vaccines are now a <strong>high-growth segment<\/strong> in biopharma exports. As health systems prioritize <strong>prevention<\/strong>, pharma buyers &mdash; from <strong>governments to NGOs<\/strong> &mdash; need <strong>trusted, scalable<\/strong> sourcing options.<\/p>\n\n\n\n<p>Platforms like <a href=\"https:\/\/pharmint.net\/\" data-type=\"link\" data-id=\"https:\/\/pharmint.net\/\">Pharmint<\/a> are enabling faster, safer access to essential vaccines across borders and in <strong>african countries.. <\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>With the spread of dengue accelerating, <strong>Qdenga is a timely solution<\/strong>. It reflects a broader shift in global healthcare &mdash; where <strong>prevention, innovation, and digital trade<\/strong> converge. As pharma sourcing becomes more digital and demand intensifies, Qdenga could be the first of many vaccines to reshape <strong>global preventive care<\/strong>.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\">\n","protected":false},"excerpt":{"rendered":"<p>As dengue cases surge worldwide, demand for effective vaccines is rising fast. Qdenga, a dengue vaccine developed by Takeda, is gaining traction in key markets across Asia and Latin America. Its broad approval and strong efficacy make it a critical tool in public health campaigns. Governments and global health organizations are accelerating vaccine procurement. Qdenga&#8217;s [&hellip;]<\/p>\n","protected":false},"author":4862,"featured_media":1737796,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rank_math_lock_modified_date":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[827],"tags":[],"class_list":["post-1737795","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"_links":{"self":[{"href":"https:\/\/pharmint.net\/fr\/wp-json\/wp\/v2\/posts\/1737795","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmint.net\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmint.net\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmint.net\/fr\/wp-json\/wp\/v2\/users\/4862"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmint.net\/fr\/wp-json\/wp\/v2\/comments?post=1737795"}],"version-history":[{"count":2,"href":"https:\/\/pharmint.net\/fr\/wp-json\/wp\/v2\/posts\/1737795\/revisions"}],"predecessor-version":[{"id":1737850,"href":"https:\/\/pharmint.net\/fr\/wp-json\/wp\/v2\/posts\/1737795\/revisions\/1737850"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmint.net\/fr\/wp-json\/wp\/v2\/media\/1737796"}],"wp:attachment":[{"href":"https:\/\/pharmint.net\/fr\/wp-json\/wp\/v2\/media?parent=1737795"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmint.net\/fr\/wp-json\/wp\/v2\/categories?post=1737795"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmint.net\/fr\/wp-json\/wp\/v2\/tags?post=1737795"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}